Also trades as: BTI.V (TSXV) · $vol 0M
BIOAF OTC
Bioasis Technologies Inc.
1W: +0.0%
1M: +0.0%
3M: +0.0%
YTD: -50.0%
1Y: -50.0%
3Y: -99.4%
5Y: -100.0%
$0.00
+0.00 (+0.00%)
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
Dark Pool
Short Interest
Income Trends
Revenue
$38K
-99.1% ▼
5Y CAGR: -40.7%
Gross Profit
-$1M
-141.8% ▼
Operating Income
-$5M
-462.1% ▼
Net Income
-$3M
-523.8% ▼
EPS (Diluted)
$-0.04
-498.1% ▼
EBITDA
-$4M
-908.3% ▼
Profit Margins
Year-over-Year Growth
View Full Income Statement
| Line Item | FY2018 | FY2019 | FY2020 | FY2021 | FY2022 |
|---|---|---|---|---|---|
| Revenue | $590K | $1M | $606K | $4M | $38K |
| YoY Growth | +15.0% | +141.1% | -57.4% | +572.5% | -99.1% |
| Cost of Revenue | $468K | $10K | $0 | $1M | $1M |
| Gross Profit | $122K | $1M | $606K | $3M | -$1M |
| Gross Margin | 20.7% | 99.3% | 100.0% | 69.6% | -3150.2% |
| R&D Expenses | $947K | $2M | $2M | $1M | $1M |
| SG&A Expenses | $4M | $4M | $3M | $2M | $2M |
| Operating Expenses | $5M | $6M | $5M | $4M | $4M |
| Operating Income | -$5M | -$6M | -$5M | -$858K | -$5M |
| Operating Margin | -887.6% | -438.7% | -856.5% | -21.0% | -12784.5% |
| Interest Expense | $0 | $0 | $47K | $0 | $654K |
| Income Before Tax | -$5M | -$3M | -$4M | $698K | -$3M |
| Tax Expense | $31K | -$1M | $0 | $0 | $0 |
| Net Income | -$5M | -$3M | -$4M | $698K | -$3M |
| Net Margin | -899.9% | -244.3% | -669.0% | 17.1% | -7846.5% |
| EPS (Diluted) | $-0.10 | $-0.06 | $-0.07 | $0.01 | $-0.04 |
| EBITDA | -$5M | -$5M | -$5M | $438K | -$4M |
| Shares Outstanding | 51M | 57M | 62M | 68M | 72M |